跳至主要内容
临床试验/NCT00366717
NCT00366717已完成不适用

Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy

Mackay Memorial Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2005年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1

研究概览

简要总结

Cytomegalovirus (CMV) infects most of the world population. This study is to understand if chemotherapy will increase the chance of reactivating CMV. The results may help us in determining when treatment is needed and perhaps Why is it needed.

详细描述

Despite CMV reactivation has been clearly described in patients underwent transplantation, this phenomenon has not been studied in patients undergoing chemotherapy. Our purpose is to understand if CMV number increases in monocytic leukocytes during chemotherapy and how is the host response to that changes.

Virus load will be studied by quantitative PCR, host response will be studied by measuring patient's anti-CMV IgG, CMV-associated symptoms, serum IFN-r and TNF-a.

研究设计

研究类型
Observational
观察模型
Defined Population
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • clinical diagnosis of any cancer
  • chemotherapy is needed for more than 6 months
  • age>20 years old

排除标准

  • those who do not agree to participate

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Cytomegalovirus Reactivation in Cancer Patients... | 临床试验